Standardization of herbal drugs refers to “confirmation of its identity and determination of its quality, purity and detection of nature of adulterant by various parameters”.
Standardization of herbal drugs refers to “confirmation of its identity and determination of its quality, purity and detection of nature of adulterant by various parameters”.
herbal drugs or phytoconstituents used to improve skin texture and coloration included in the presentation with herbal fairness formulations available in the market
Process of implementing and developing technical standards based on the consensus of different parties that include firms, users, interest groups, standards organizations and governments
This presentation intends to introduce about ayurvedic tablets known as gutikas or vatis. The content is suitable for undergraduate pharmacy students and high school science learners. It focusses on preparation and standardization. This topic is part of herbal drug technology of B.Pharmacy PCI curriculum.
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
herbal drugs or phytoconstituents used to improve skin texture and coloration included in the presentation with herbal fairness formulations available in the market
Process of implementing and developing technical standards based on the consensus of different parties that include firms, users, interest groups, standards organizations and governments
This presentation intends to introduce about ayurvedic tablets known as gutikas or vatis. The content is suitable for undergraduate pharmacy students and high school science learners. It focusses on preparation and standardization. This topic is part of herbal drug technology of B.Pharmacy PCI curriculum.
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
Evaluation of Preliminary phytochemical on various some medicinal plantspharmaindexing
The present study was carried out to evaluate the physical status and percentage yield of methanolic extract and its fractions of whole plant of Leucas cephalotes, leaves of Hiptage benghalensis and leaves of Kydia calycina were recorded for future references and Preliminary phytochemical screening of MLC, MHB and MKC revealed the presence of carbohydrates, glycosides, saponins, flavonoids, steroidal and phenolic compounds. MLC revealed the presence of all the above mentioned phytoconstituents except saponins and also MKC steroidal compounds. The fractions of MLC, MHB and MKC revealed the presence of glycosides, phenolic compounds, steroids and flavonoids.
Comparative Phytochemical and Physicochemical Study of Tulsi (Ocimum sanctum)...BRNSS Publication Hub
Curcuma longa belongs to family and ocimum sanctum belongs to family lamiaceae. The phytochemical and physicochemical analysis was carried out for tulsi and haldi and haldi and a comparative study were done. Determination of total ash, acid insoluble, water soluble ash of tulsi and haldi were carried out by using standard procedure. The phytochemical screening has been done for different extract it revealed the presence of alkaloid, flavanoid, tannin, carbohydrate. Phytochemical and physicochemical parameters of Tulsi and haldi were stablished for their identification. The present study is focused on phytochemical and physicochemical study on haldi and tulsi. The qualitative physicochemical analysis was performed for the detection of secondary metabolites (viz. alkaloid, protein, tannin, saponin etc.).
extraction of bioactive compounds from plant sources using maceration processNivaasvignopathy
extraction of bioactive compounds from plant sources using maceration process.Maceration is a technique used in wine making and has been adopted in medicinal plant research.
Membrane Stabilizing And Antimicrobial Activities Of Caladium Bicolor And Che...IOSR Journals
The crude methanol extracts of whole plant of Caladium bicolor (Aiton) Vent. and leaf of Chenopodium album L. as well as their pet-ether, carbon tetrachloride, chloroform and aqueous soluble fractions were evaluated for membrane stabilizing and antimicrobial activities. At concentration 1.0 mg/ml, the carbon tetrachloride soluble fraction of C. bicolor inhibited 43.92±1.63% and 38.08±0.83 % hypotonic solution and heat induced haemolysis of RBCs, respectively. Among the extractives of C. album, the aqueous soluble fraction inhibited 47.11±0.49 % and 36.73±0.76 % hypotonic solution and heat induced haemolysis of RBCs as compared to 72.79 % and 42.12 % by acetyl salicylic acid (0.10 mg/ml), respectively. C. bicolor test samples demonstrated zone of inhibition ranging from 6.0 to 20.0 mm. The chloroform soluble fraction showed the highest zone of inhibition (20.0 mm) against Staphylococcus aureus. The test samples of C. album displayed zone of inhibition ranging from 7.0 to 13.0 mm. The highest zone of inhibition (13.0 mm) was showed by the chloroform soluble fraction against Salmonella paratyphi
Solvent extraction of salvia leaves by decantation using the solvent methanolVWR INTERNATIONAL
Introduction
Literature review
Methodology of decantation followed by rotary evaporator
Yield of extract
Phytochemical screening methods
Result
Conclusion
References
ABSTRACT
The traditional medicine involves the use of different plant extracts or the bioactive constituents. The study
such as ethno medicine keenly represents one of the best avenues in searching new economic plants for
medicine. This type of study provides the health application at affordable cost. The present study carried out to
find out the phytochemical constituents in the Ficusracemosa leaves. The materials were grained and extracted
with benzene, ethanol, ethyl acetate, and methanol and petroleum ether. Photochemical analysis was carried
out according to standard procedures. Sugar, protein, alkaloids, flavonoids, sterols and glycoside were found
to be present in the extracts.
KEY WORDS
Ficusracemosa (linn.)moraceae, Pharmacological and Phytochemical studies.
Similar to Analysis of ayurvedic formulations (20)
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
2. CONTENTS
Introduction to Ayurveda and Ayurvedic
formulations.
Analysis of Ayurvedic drugs
Analysis of Brahmi hills
Analysis of Diabohills juice
Analysis of Ashwagandha capsules
Analysis of Avaleha
Conclusion
References
2
3. INTRODUCTION
Ayurvedic medicine is a system of healing that originated
in ancient India.
In sanskrit
Ayur – Life or Living
Veda – Knowledge
So, Ayurveda has been defined as the “Knowledge of
living” or the “Science of longevity”.
3
4. Ayurveda is the science of health and healing practised by
ancient aryans which is based on the Atharvaveda, one of the
oldest scriptures of Hindus, about 3000 years old.
The object of ayurveda is to counteract the imbalance of three
essential elements, vata, pitta, kapha(air,bile and phlegm
respectively),which constitute the Tridosha from which the
body originates.
According to Drugs and Cosmetic Act 1940,ayurvedic
medicine includes all medicines intended for internal or
external use, for or in the diagnosis, treatment, mitigation or
prevention of disease or disorder in human beings or animals.
4
5. According to hypothesis of Ayurveda, the entire universe is
composed of five basic elements called
PANCHAMAHABHUTA and include space, air, energy ,liquid,
and solid.
The variable combinations of these principles make tridosha in
human body.
These combinations are vata, pitta and kapha.
They have been interpreted in the following way.
Vata is composed of space and air. It is concerned with the
physical and mental activities which are activating or dynamic
in nature.
5
6. Vata represents nervous system,or nadichakra as per ayurvedic
terminology.
Pitta is composed of liquid and energy, and indicates
biochemical or energy systems.
Kapha is composed of solid and liquid and indicates various
tissues and organs.
Ayurvedic therapeutics is based on five pharmacological
principles (panchsheel) of the drug.
Those are as follows:
1.Rasa 2.Guna 3.Vipaka 4.Virya 5.Prabhava. 6
7. AYURVEDIC FORMULATIONS:
Different solvents (menstrum) used in preparations of
Ayurvedic formulations are water ,oils ,milk ,ghee ,cow’s
urine ,etc.
The use of sweetening agents ,binding agents, colorants,
flavouring principles, and other adjuvents is also very
common in ayurvedic preparations.
With an objective of obtaining maximum therapeutic
benefit and making the formulation palatable, different
pharmaceutical process are prescribed in ayurveda.
7
8. Arka
Asava and Arishta
Avaleha or Leha and Paka
Bhasma
Churna
Dravaka
Fant
Ghana-saar
Ghrita(snehkalpa)
Kalka
Kajjali
Ksharas
Kvatha(Decoction)
Kupipakva Rasayana
8
The Important Ones Are As Follows:
Lepa
Matras
Nassyas
Netrabindu and anjana
Nikadha
Parpati kalpas
Pisti
Praash
Rasa-yoga
Sattva
Siddha-milks
Swarasa
Taila (Medicated oils)
Vatika and Gutika
9. ANALYSIS OF AYURVEDIC DRUGS:
Several Ayurvedic medicines readily available are found
to contain steroids and heavy metals ,both are harmful to
the human body if taken in excess.
Ayurvedic medicines given by the vaidyas –be it in the
form of bhasma or churna which people swallow in with
great faith,could contain steroid and toxic metals such as
lead,mercury and arsenic.
9
10. In order to ensure quality control,quality assurance and safety
for ayurveda and siddha drugs, the quality of herbal products
need to be monitored with creation of awareness amongst all
concerned i.e.;
Physical analysis
Chemical analysis
Microbial analysis
10
11. BRAHMI
Synonym: Bacopa monnieri
Biological source:
It consists of dried whole plant, preferably the
fresh leaves and the stem of the plant known
as Bacopa monnieri(Linn.)
Belonging to family Scrophulariaceae and
should contain not less than 2.5% of bacoside
A calculated on the dried basis.
11
12. Geological source:
It is glabrous, succulent, small, prostrate or creeping
annual herb found in throughout India, in wet, damp and
marshy places, up to 1200m elevation.
Macroscopic characters:
Root - Thin, wiry, small, branched creamish-yellow.
Stem - Thin, green or purplish green, about 1-2 mm thick,
soft, nodes and internodes are prominent, glabrous;
taste, slightly bitter.
12
13. Leaf - Simple, opposite, decussate, green, sessile, 1-2 cm long,
obovate-oblong; taste, slightly bitter.
Flower - Small, axillary and solitary, pedicels 6-30 mm long,
bracteoles shorter than pedicels.
Fruit - Capsules up to 5 mm long, ovoid and glabrous.
CHEMICAL CONSTITUENTS:
Brahmi is found to contain the alkaloids, brahmine, herpestine,
and the mixture of other three alkaloids.
It contains saponins, namely bacosides A and B. Additionally,
It also contains betulicacid, stigmasterol, monnierin and
hersaponin. 13
14. .
USES:
It is used as nervine tonic,in the treatment of asthma, Epilepsy.
And also used as diuretic and the alcoholic extract of entire
plant is found to have anti-cancer activity.
Important formulations:
Sarasvatarista,
Brahmi Ghrita,
Ratngiri Rasa,
Brahmi vati,etc..
14
15. BRAHMI GHRITA
A polyherbal Ayurvedic formulation.
Preparation: Whole plant of Brahmi was
collected and other ingredients which are
used in the preparation of Brahmi
Ghrita,all are identified and authenticated
in pharmacognosy laboratory.
Brahmi swarasa was extracted by exerting
mechanical pressure on fresh brahmi.
15
16. In a large vessel, Go-Ghrita was poured, when it
liquefies under moderate flame, kalka of vacha, kushtha,
shankhapushpi made in Brahmi swarasa was added,
followed by the addition of Brahmi swarasa.
To get final product, the contents were subjected to heat
till upto the Sneha Siddhi Lakshanas were observed.
PHYSICOCHEMICAL STUDY OF BRAHMI GHRITA:
Brahmi ghrita was analysed with various standard
physico-chemical parameters such as :
16
17. Acid-value – NMT 2
Saponification value – 190 to 230
Refractive index value at 400 – 1.454 to 1.465
Iodine value – 30 to 40
Peroxide value – NMT 4
Specific gravity
HPTLC
Wt/ml at 400 - 0.930g to 0.945g
Congealing point – 210 to 170
17
18. IDENTIFICATION
Thin layer chromatography:
Extract 2 g of the sample with 20 ml of alcohol (400 for 3 hrs).
Cool, separate the alcohol layer,
Filter, concentrate to 5 ml
carry out the thin layer chromatography.
Apply 10 μl of the extract on TLC plate
18
19. develop the plate to a distance of 8 cm
{Mobile phase: toluene : ethyl acetate : hexane (6 : 3 : 1)}
allow the plate to dry in air
spray with ethanol-sulfuric acid reagent
heating at 1100c for about 10 min.
It shows major spots at Rf 0.15, 0.28, 0.40 and 0.51
(all light grey) under visible light. 19
20. HPTLC
Preparation of sample solution:
The Ghrita sample was adsorbed on silica gel .
The mixture was extracted with hexane.
Hexane fraction was discarded .
The material was extracted with methanol.
Process was repeated for 3 times .
The methanol layer was collected ,filtered , and evaporated off.
The dried material was again dissolved in methanol and used
for TLC identification.
20
21. CHROMATOGRAPHIC CONDITIONS :
1 . Stationary phase :silica gel GF precoated TLC plates.
2 . Mobile phase : Dichloromethane : methanol : water
(4.5 : 1.0 : 0.1 v / v / v).
Sample volume : 5 ml
Sample for HPTLC : Methanol of Brahmi Ghrita.
Spray Reagent:Vaniline-sulphuric acid.
21
22. PROCEDURE :
Before spotting , the plates were prepared with methanol.
Sample solutions were applied to the plates as sharp bands.
The spots were dried in a current of air.
The mobile phase (20ml) was poured into a twin trough glass
chamber, whole assembly was left to equilibrate for 30 min and
the plate was placed in the chamber.
The plate was then developed until the solvent front had
travelled at a distance 80mm above the base of the plate. 22
23. The plate was then removed from chamber
and dried in a current of air.
Detection and quantification was performed
with camag TLC scanner 3 at a wavelength
of 254 and 366 nm .
It shows major spots at Rf 0.78 (pink color)
which indicates the presence of Bacoside A.
23
25. BENEFITS:
In ayurveda brahmi has been historically used to aid
cognitive brain function.
It is cooling and helps in managing of stress.
It has anti-stress properties.
It is a cooling agent.
25
26. ANALYSIS OF BRAHMI CAPSULES BY
HPTLC
PREPARATION OF SAMPLE SOLUTION:
Capsule is a modern solid dosage form in which the
powdered crude drug or extract of the herb is filled into the
shells of the capsules.
2 g of capsule content was transferred to 100 ml volumetric
flask containing 50 ml of methanol and the mixture was
macerated on a shaker for 24 hrs at room temperature.
Then 1.0 ml of this extract was diluted to a 10 ml with
methanol. 26
27. PREPARATION OF STANDARD SOLUTION:
It is prepared by dissolving 5.0 mg of bacoside A in 10 ml
methanol, yielding stock solution of concentration = 0.5mg
ml-1.
THE MOBILE PHASE: Toluene: ethyl acetate: methanol: Gla.
acetic acid (3:4:2.5:1) v/v
PROCEDURE
The sample solutions were spotted on the precoated silica gel
aluminum plate 60F254.
The plates were pre-washed by methanol and activated at
60°C for 5 min prior to chromatography.
27
28. 15 ml of mobile phase was used per chromatography. Linear
ascending development was carried out in twin trough glass
chamber saturated with the mobile phase.
The length of chromatogram run was 8 cm.
TLC plates were dried in a current of air with the help of an
air dryer.
Densitometric scanning was performed with Camag TLC
scanner III in the reflectance-absorbance mode at 540 nm
after spraying with 10% Sulfuric acid alcohol reagent (Acid
alcohol) .
28
29. DIABOHILLS JUICE
INTRODUCTION:
It is a quality product containing
EUGENIA JAMBOLANA +MOMODICA CHARANTIA as
its ingredient.
Diabohill juice is potent combination of Bitter Gourd and
Amla.
Synonyms: karela -jamun juice
Phyto constituents: Glucoside, saponin (0.5% charaantin),
aromatic volatile oils,7% bitter principles.
29
30. Fruits and leaves: Momordicine, ascorbigen, aspartic acid,
serine, glutamic acid, threonine, alanine, g-aminobutyric
acid and pipecolic acid.
USES:
Diabohills juice is very effective in non-insulin dependent
diabetes.
It is also helps in reducing fasting blood sugar too.
And it is also used as:
Anti diabetic , Hypoglycemic
Antibiotic, Anti mutagenic ,Antioxidant etc.. 30
31. HERBAL HILLS : DIABOHILLS (KARELA –JAMUN JUICE)
INGREDIENTS: Jambu, Karela, Guduchi,
Baheda, Harde, Sunthee, Amla, Turmeric,
Neem, Fenugreek, Gurmar, Ashwagandha,
Kadu Chirayati, shatavari.
DIRECTIONS: Take 30ml juice mixed with 100ml
water or fruit juice or have it plain.
PART USED FOR JUICE: Pulp of jamun and fruit of
karela.
31
32. MANUFACTURING PROCESS OF DIABOHILLS
JUICE AT HERBAL HILLS
STEP: 1
PROCESSING RAW HERBS:
All the raw material karela, amla fruit ,harde, baheda,
neem, methi, ambehaldi, sunthee, shatavari,
Ashwagandha, Kadu Chirayati, bel leaves, and gudmar
are washed, cut and crushed in to small pieces.
STEP: 2
The mixture is boiled at 1100c
The boiled material is then cooled at room
temperature.
32
33. STEP 3:
The pulp of Jamun (seeds of jamun are not used) is
prepared and mixed with all the above ingredients and
crushed and water is added.
After addition of preservative, the homogenized mixture
is mixed thoroughly and in process sample is taken and
sent for testing.
The sample passing the specifications are taken for
packing.
STEP 4:
The bottles are labeled and packed as per guidance. 33
35. ASHWAGANDHA CAPSULES
Synonym : Withania root , Winter cherry
Biological source:
It consists of dried mature roots of withania
somnifera (linn) Dunal; belonging to the
family Solanaceae and should contain not
less than 0.02% of total withanolide A and
withaferin A on dried basis.
Chemical constituents:
The main constituents are alkaloids and
steroidal lactones.
35
36. The main alkaloid is the withanine and other alkaloids
are somniferine, somnine, somniferinine, withananine,
pseudo-withanine, tropine, pseudo-tropine and
anahydrine.
Two acyl steryl glucosides viz.sitoindoside vii and
sitoindoside viii have been isolated from roots.
Therapeutic uses:
Anxiety, stress, depression, Muscle fatigue and
neck/back stiffness, arthritis of all types, blood
pressure, Insomina, diabetic neuropathy, muscle
power and stamina, weakness due to Diabeties. 36
37. Composition of capsule:
Each 500 mg capsule contains:
Concentrated extract of withania …..400mg
Excipients ………q.s
(A) Powder study: The shade dried roots of the plant were
powdered and pass through sieve 60# and used for the observation
of microscopical characters.
The powder drug + Phloroglucinol:HCl(1:1) Lignified cells
The powder drug + Lacto phenol Calcium oxalate crystals
The powder drug + Iodine solution Starch grains 37
38. (B).EVALUATION OF QUALITY CONTROL
PARAMETERS FOR RAW MATERIALS:
PHYSICO CHEMICAL PARAMETERS:
Foreign organic matter:NMT 2%
Total ash :NMT 7%
Acid-insoluble ash :NMT 1%
Alcohol soluble extractive :NMT 15%
Ethanol soluble extractive :NMT 10%
Water soluble extractive : Nil
Loss on drying : NMT 12% determined on 5g by drying
in an oven at 1050.
38
39. DETERMINATION OF pH:
The pH value of a solution was determined
potentiometrically by means of a glass electrode, a
reference electrode and a digital pH meter.
First the apparatus was calibrated using buffer of 4,9 and
7pH.
1gm of powdered extract was taken and dissolved in
100ml of demineralized water.
The electrodes were immersed in the solution and the pH
was measured. 39
40. QUALITATIVE PHYTOCHEMICAL EVALUATION:
TEST FOR ALKALOIDS:
Mayer’s test:
The small portions of solvent free chloroform, alcoholic
and water extracts are stirred separately with a few drops
of dil.HCl and filtered.
The filtrate may be tested carefully with various
alkaloidal reagents such as Mayer's reagent, cream ppt
formed.
It indicates the presence of alkaloids.
40
41. Drug extract + Dragendorffs reagent orange brown ppt.
Drug extract + Hager's reagent yellow ppt.
Drug extract + Wagers reagent reddish-brown ppt.
TEST FOR GLYCOSIDES:
GENERAL TEST: Extract 200mg of the drug using 5ml of
dilute (10%) sulphuric acid and boil on waterbath.
After boiling add equal volume of water to the volume of
NaOH .
41
42. Add 0.1ml of Fehlings reagent A and B alkaline (red
litmus changes to blue ) and heat on water bath for 2
min.
Note the red ppt formed represents the glycoside after
acid hydrolysis.
TEST FOR SAPONINS:
Frothing test:The sample drug was vigorously shaken
with distilled water and was allowed to stand for 10 min.
Stable froth more than 1.5cm indicates the presence of
saponins.
42
43. TEST FOR TANNINS:
Ferric chloride test: The water extract of the sample drug was
treated alcoholic ferric chloride.
Blue colour indicates the presence of tannins.
Lead acetate test: With 5% lead acetate solution tannins give
ppt which turns to red colour on addition of KOH solution
,on excess addition ppt is dissolved.
43
44. TEST FOR CARBOHYDRATES:
Molisch’s test:
Small quantities (200mg) of alcoholic and aqueous extract are
dissolved seperately in 5ml of distiiled water and filtered.
The filtrate is treat with Molisch’s reagent.
It gives red or purple colored compound.
It indicates the presence of carbohydrates.
44
45. EVALUATION OF QUALITY CONTROL PARAMETERS FOR
FINISHED PRODUCT(CAPSULES):
DISINTEGRATION TEST FOR CAPSULES:
Disintegration test was performed using the digital
microprocessor based disintegration test apparatus by VEEGO.
One capsule was introduced into each tube and added a disc to
each tube.
The assembly was suspended in the water in a 1000ml beaker.
45
46. The volume of water was such that the wire mesh at its highest
point is atleast 25mm below the surface of the water,and at its
lower point was at least 25mm above the bottom of the beaker.
The apparatus was operated and maintained with temperature
at 37 + 20 c.
Noted down the time require to all capsules to disintegrate and
pass through wire mesh.
LIMITS: disintegration time must not be more than 30mins.
46
47. DISSOLUTION TEST FOR CAPSULES:
The dissolution test was performed for capsule using USP
dissolution apparatus 2 by VEEGO.
The 900 ml of the 5N HCl as dissolution medium was
introduced into the vessel of the apparatus.
The dissolution medium was warmed to 36.5 -37.50c.
For the capsules basket type dissolution apparatus was
used.
47
48. The apparatus was operated immediately at the speed of
50 rpm for 2 hrs.
After 2 hrs a 25ml specimen was withdrawn from a zone
midway between the surface of the dissolution medium
and top of the rotating blade or basket,in evaporating dish.
Filter and evaporate the specimen.
For the each of the capsule tested, the amount of dissolved
active ingredients in the solution was calculated as a
percentage dissolved in 2 hrs.
LIMITS: Dissolution of capsules should not be less than
70%. 48
49. MICROBIAL ANALYSIS:
The test included total bacterial count, total yeast, and mould
count.
And also the identification of specified organisms such as
Escherichia coli, Salmonella species, Staphylococcus aureus,
and pseudomonas aeuruginosa.
49
50. AVALEHA
Avaleha or Lehya is a semisolid preparation of drugs,
prepared with addition of jaggery,sugar or sugar-candy and
boiled with prescribed juices or decoction.
These preparations generally have
1) Kasaya or other liquids
2) Jaggery ,sugar or sugar-candy
3) Powders or pulps of certain drugs
4) Ghee or oil
5) Honey
50
51. Jaggery, sugar or sugar-candy is dissolved in the liquid and
strained to remove the foreign particles.
This solution is boiled over a moderate fire.
When pressed between two fingers if paka becomes thready,
or when it sinks in water without getting easily dissolved, it
should be removed from the fire.
Fine powders of drugs are then added in small quantities
and stirred continuosly to form a homogeneous mixture.
51
52. Ghee or oil, if mentioned, is added while the preparation is
still hot and mixed well.
Honey, if mentioned is added when the preparation becomes
cool and mixed well.
The Lehya should neither be hard nor a thick fluid .
When pulp of the drugs is added and ghee (or) oil is present
in the preparation, this can be rolled between the fingers.
When metals are mentioned, the bhasmas of the metals are
used.
In case of drugs like Bhallataka,purification process is to be
followed.
52
53. The lehya should be kept in glass or porcelain jars.
It can also be kept in a metal container which does not react
with it .
Normally Lehyas should be used within one year.
Eg. Kalyanavaleha, Draksavaleha, vasavaleha, bilvadileha and
surnavaleha.
53
54. KALYANAVALEHA
Definition: Kalyanavaleha is a semisolid preparation made with
the ingredients of the formulation composition given below…
Haridra API
Vaca API
Kustha API
Pippali API
Sunthi API
Ajaji API
Ajamoda API
54
55. Yasthi madhu API
Saindhava lava API
Sarpi API
METHOD OF PREPARATION:
Take all ingredients ,clean and dry and powder the ingredients
numbered 1 to 9 seperately and pass through the sieve number
85.Mix all the ingredients thoroughly.
Add sarpi to the mixture ,stir thoroughly to form a semisolid
mass.
Pack it in tightly closed containers to protect from light and
moisture.
55
56. DESCRIPTION:
Semisolid paste, yellowish-brown in color with pungent
odour, astringent and salty taste.
IDENTIFICATION:
THIN LAYER CHROMATOGRAPHY:
Defat 5mg of kalyanavaleha with 75ml of n-hexane under
reflux on a water-bath for 30 min.
Filter and discard the hexane extract.
Extract the defatted marc with 75ml of chloroform under
reflux for 30 min. 56
57. Filter and concentrate the extract to 10 ml and carry out the TLC.
Apply 10ml of the chloroform extract on TLC plate and develop
the plate to a distance of 8cm using
toulene:ethylacetate:methanol (9:1:1) as Mobile Phase.
After development allow the plate to dry in air and examine
under UV light (366nm).
It shows major spots at Rf 0.22(blue), 0.29,0.45(both yellow),
0.60,0.68(both blue).
57
58. CHEMICAL TESTS:
1.Avaleha + conc.sulphuric acid orange red color
{presence of curcuminoids(Haridra)}.
2. Avaleha + 10% sol. of NaOH /KOH red to violet
color (indicating the presence of curcuminoids).
58
59. PHYSICO CHEMICAL PARAMETERS:
Loss on drying :NMT 5.5%
Total ash :NMT12.0%
Acid-insoluble ash :NMT 2.0%
Alcohol soluble extractive :NLT 46.0%
Water soluble extractive :NLT 11.0%
PH (1% aqueous solution ) :5.1 and 5.3
Starch :NLT 42.0%
59
60. OTHER REQUIREMENTS:
MICROBIAL LIMITS:
These microbial limit tests are performed for the estimation of
the no. of viable aerobic micro-organisms present and for
detecting the presence of designated microbial species in
pharmaceutical substances.
AFLATOXINS:
These are highly dangerous toxic substances,extreme care
should be taken while handling these aflatoxin material. 60
61. This aflatoxin test can be performed to detect the presence
of aflatoxins in any material of plant origin.
STORAGE:
Store in a cool place in tightly closed containers,protected from
light and moisture.
THERAPEUTIC USES:
Svarabhedha(hoarseness of voice)
Mukata (Aphasia)
61
62. CONCLUSION
By performing the analysis of ayurvedic formulations or
preparations, all the macroscopic, microscopic, physical,
and chemical characteristics of the formulations can be
determined .
If any undesirable effects may be identified during
analysis, they can be reduced to acceptable levels, leads
to get good therapeutic effect without any adverse
reactions.. 62
63. REFERENCES
Text book of pharmacognosy by C.K.Kokate.
The Ayurvedic pharmacopoeia of India part-II (formulations);
volume-I
International Journal of Applied Biology and Pharmaceutical
Technology.
Journal of Analytical profile of Ayurvedic Formulations.
Anonymous. (1996). Indian Pharmacopoeia, Vol. II,
Government of India, Ministry of Health and Family Welfare,
New Delhi, A-81-83, 95, 736.
63